Literature DB >> 21598809

Bypassing the emergency room to reduce door-to-balloon time and improve outcomes of patients with ST elevation myocardial infarction: the Acute Coronary Syndrome Israeli Survey experience.

Alla Lubovich1, Hatem Hamood, Solomon Behar, Uri Rosenschein.   

Abstract

BACKGROUND: Rapid reperfusion of an infarct-related artery is crucial for the successful treatment of ST elevation myocardial infarction. Every effort should be made to shorten door-to-balloon time.
OBJECTIVES: To investigate whether bypassing the emergency room (ER) has a positive influence on door-to-balloon time in patients presenting with ST elevation myocardial infarction (STEMI) and whether the reduction in door-to-balloon time improves patients' clinical outcome.
METHODS: We analyzed data of 776 patients with STEMI from the 2004 and the 2006 Acute Coronary Syndrome Israeli Survey (ACSIS) registry. The ACSIS is a biennial survey on acute myocardial infarction performed in all 25 intensive cardiac care units in Israel during a 2-month period. Twenty-five percent of patients (193 of 776) arrived directly to the intensive cardiac care unit (ICCU) and 75% (583 of 776) were assessed first in the ER. We compared door-to-balloon time, ejection fraction, 30 days MACE (major adverse cardiac and cerebrovascular events) and 30 days mortality in the two study groups.
RESULTS: There was significantly shorter door-to-balloon time in the direct ICCU group as compared with the ER group (45 vs. 79 minutes, P< 0.002). Patients in the direct ICCU group were more likely to have door-to-balloon time of less than 90 minutes in accordance with ACC/AHA guidelines (88.7% vs. 59.2%, P < 0.0001). Moreover, patients in the direct ICCU group were less likely to have left ventricular ejection fraction < 30% (5.4% vs. 12.2%, P= 0.045) and less likely to have symptoms of overt congestive heart failure. Lastly, 30 days MACE was significantly lower in the direct ICCU group (22 vs. 30%, P< 0.004).
CONCLUSIONS: There is significant reduction of the door-to-balloon time in the direct ICCU admission strategy. This reduction translates into improvement in clinical outcome of patients. It is reasonable to apply the direct ICCU strategy to patients with STEMI.

Entities:  

Mesh:

Year:  2011        PMID: 21598809

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Mortality and ST resolution in patients admitted with STEMI: the MOMI survey of emergency service experience in a complex urban area.

Authors:  Niccolò Grieco; Giovanni Sesana; Elena Corrada; Francesca Ieva; Annamaria Paganoni; Maurizio Marzegalli
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

Review 2.  The impact of direct admission to a catheterisation lab/CCU in patients with ST-elevation myocardial infarction on the delay to reperfusion and early risk of death: results of a systematic review including meta-analysis.

Authors:  Magnus Andersson Hagiwara; Anders Bremer; Andreas Claesson; Christer Axelsson; Gabriella Norberg; Johan Herlitz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-11-25       Impact factor: 2.953

3.  Trends in the management and outcomes of patients admitted with acute coronary syndrome complicated by cardiogenic shock over the past decade: Real world data from the acute coronary syndrome Israeli survey (ACSIS).

Authors:  Eran Kalmanovich; Alex Blatt; Svetlana Brener; Meital Shlezinger; Nir Shlomo; Zvi Vered; Hanoch Hod; Ilan Goldenberg; Gabby Elbaz-Greener
Journal:  Oncotarget       Date:  2017-06-27

4.  Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.

Authors:  Lior Lupu; Louay Taha; Ariel Banai; Hezzy Shmueli; Ariel Borohovitz; Shlomi Matetzky; Mustafa Gabarin; Mony Shuvy; Roy Beigel; Katia Orvin; Sa'ar Minha; Yacov Shacham; Shmuel Banai; Michael Glikson; Elad Asher
Journal:  Clin Cardiol       Date:  2022-03-09       Impact factor: 3.287

5.  Regional disparities in mortality after ischemic heart disease in a Brazilian state from 2006 to 2010.

Authors:  Luciano de Andrade; Vanessa Zanini; Adelia Portero Batilana; Elias Cesar Araujo de Carvalho; Ricardo Pietrobon; Oscar Kenji Nihei; Maria Dalva de Barros Carvalho
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.